NeoGenomics

+$0.66 (+8.02%) Today
-$0.16 (-1.80%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NeoGenomics and other ETFs, options, and stocks.

About NEO

NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. It operates through the Clinical Services and Pharma Services segments.

CEO
Lynn A. Tetrault
Employees
2,000
Headquarters
Fort Myers, Florida
Founded
1998

NEO Key Statistics

Market cap
1.11B
Price-Earnings ratio
—
Dividend yield
—
Average volume
1.50M
High today
$8.95
Low today
$8.35
Open price
$8.36
Volume
854.75K
52 Week high
$54.74
52 Week low
$7.26

NEO News

Simply Wall St18h

Loss-making NeoGenomics sheds a further US$60m, taking total shareholder losses to 80% over 1 year - Simply Wall St

The art and science of stock market investing requires a tolerance for losing money on some of the shares you buy. But it's not unreasonable to try to avoid tru

NEO Earnings

-$0.23
-$0.11
$0.02
$0.14
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 5, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure